Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 921-930 of 1760 for cancer

Edit search filters
  1. A Study To Evaluate Daratumumab And Ibrutinib To Treat Relapsed / Refractory Chronic Lymphocytic Leukemia Treatment (DIRECT)

    Jacksonville, FL

  2. Cerebrospinal Fluid Biomarkers For Brain Tumors

    Rochester, MN

  3. Ommaya At Biopsy

    Rochester, MN

  4. Phase II Study Of Bendamustine And Rituximab Plus Venetoclax In Untreated Mantle Cell Lymphoma Over 60 Years Of Age (PrE0405)

    Rochester, MN

  5. A Study To Evaluate Daratumumab/rHuPh20 +/- Lenalidomide As Post-ASCT Maintenance For Multiple Myeloma With Minimal Residual Disease (MRD) To Direct Therapy Duration

    Scottsdale/Phoenix, AZ, Eau Claire, WI, Rochester, MN

  6. Evaluation Of De-escalated Adjuvant Radiation Therapy For Human Papillomavirus (HPV)-Associated Oropharynx Cancer

    Albert Lea, MN, Scottsdale/Phoenix, AZ, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

  7. ACP-196 In Combination With Pembrolizumab, For Treatment Of Hematologic Malignancies

    Jacksonville, FL, Rochester, MN

  8. Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme

    Rochester, MN

  9. A Study Of Afatinib Treatment For Patients With Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 Or Older

    Scottsdale/Phoenix, AZ

  10. A Study of Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms

    Rochester, MN

.

Mayo Clinic Footer